Unit 1 Seminar Dr. Daudi K. Langat Adjunct Professor, Kaplan University Welcome to the first Seminar...

download Unit 1 Seminar Dr. Daudi K. Langat Adjunct Professor, Kaplan University Welcome to the first Seminar this semester! We will begin at the top of the hour.

If you can't read please download the document

Transcript of Unit 1 Seminar Dr. Daudi K. Langat Adjunct Professor, Kaplan University Welcome to the first Seminar...

  • Slide 1

Unit 1 Seminar Dr. Daudi K. Langat Adjunct Professor, Kaplan University Welcome to the first Seminar this semester! We will begin at the top of the hour. Since this is an Audio Seminar, ensure the speakers in your Computer are set to a comfortable sound level. You will be able to ask me questions using the Text box. Slide 2 Daudi K. Langat, Ph.D Adjunct Professor Email: [email protected]@kaplan.edu AIM: Kipngetich1 (evenings and Off. hrs) Yahoo IM: dlangat (10:00 am 4:00 pm Central time in the weekdays) Office Hours: Tuesday 10:0011:59 PM ET Slide 3 We will be discussing course objectives and protocol, so come with any questions you may have. We will also discuss concepts from Chapter 11 Blood, including blood composition and blood types. Slide 4 HS13004Langat, DaudiThursday8 pm ETHS130-4 HS13005Connell, SusieThursday12 pm ETHS130-5 HS13002Abrams, TracyMonday8:00 pm ETHS130-02 Slide 5 Slide 6 Slide 7 Slide 8 We will discuss concepts from Chapter 11 Blood, including blood composition and blood types. Slide 9 Approximate values for the components of blood in a normal adult. Values will vary with age, sex, and nutritional status Slide 10 Comparison of normal and sickle-shaped RBCs (color-enhanced scanning electron micrographs [SEMs]). A, Normal red blood cells, B, Shape of RBCs in sickle cell anemia. Slide 11 Structure disk-shaped, without nuclei Functions transport oxygen and carbon dioxide Common disorders involving red blood cells: Anemia inability of blood to carry adequate oxygen to tissues; caused, for example, by: Inadequate RBC numbers Deficiency of hemoglobin Pernicious anemiadeficiency of vitamin B12 Polycythemia abnormally high RBC count Hematocrit test medical test in which a centrifuge is used to separate whole blood into formed elements and liquid fraction Slide 12 Hematocrit tubes showing normal blood, anemia, and polycythemia. Note the buffy coat located between the packed RBCs and the plasma. A, A normal percentage of red blood cells (RBCs). B, Anemia (a low percentage of RBCs). C, Polycythemia (a high percentage of RBCs). D, Photograph shows a laboratory centrifuge used to spin down tubes of whole blood to separate the formed elements from the plasma. Note the six openings that permit multiple hematocrit tubes to be processed at the same time. Slide 13 General function defense WBC count and what it shows: Differential WBC count reveals proportions of each type of WBC Leukopenia abnormally low WBC count Leukocytosis abnormally high WBC count Neutrophils and monocytes carry out phagocytosis Lymphocytes produce antibodies (B-lymphocytes) or directly attack foreign cells (T-lymphocytes) Eosinophils protect against parasitic irritants that cause allergies Basophils produce heparin, which inhibits clotting Slide 14 Each light micrograph shows a different type of stained white blood cell surrounded by several smaller red blood cells. Slide 15 Leukemia cancer Elevated WBC count Cells do not function properly Type identified by how quickly symptoms appear and cell type involved Acute lymphocytic leukemia (ALL) Acute myeloid leukemia (AML) Chronic lymphocytic leukemia (CLL) Chronic myeloid leukemia (CML) Slide 16 Platelets play an essential role in blood clotting Blood clot formation Clotting factors released at the injury site produce prothrombin activator Prothrombin activator and calcium convert prothrombin to thrombin Thrombin triggers formation of fibrin, which traps RBCs to form a clot Slide 17 A, The extremely complex clotting mechanism can be distilled into three basic steps: 1, release of clotting factors from both injured tissue cells and sticky platelets at the injury site (which form a temporary platelet plug); 2, series of chemical reactions that eventually result in the formation of thrombin; and 3, formation of fibrin and trapping of red blood cells to form a clot. B, Red and white blood cells (WBCs) entrapped in a fibrin (yellow) mesh during clot formation (WBCs are blue). Slide 18 Factor F X F IXaF IX F XIaF XI Surface Contact Collagen FXII activator F XIIaF XII Intrinsic Pathway Ca 2+ The Clotting Cascade Factor F X F VIIF VIIa F III (Tissue Thromboplastin) Tissue/Cell Defect Extrinsic Pathway Ca 2+ Fibrinogen Fibrin monomers Fibrin polymers Thrombin Prothrombin I Factor F Xa Ca 2+ Platelet Factor 3 Crosslinked Fibrin Meshwork F XIIIaF XIII F VF Va F VIIIaF VIII Slide 19 Slide 20 1. Name several substances found in blood plasma. 2. Explain the function of albumins, globulins, and fibrinogens. 3. What is the difference between serum and plasma? 4. What two types of connective tissue form blood cells? Where are they found and what do each of them form? Slide 21 Describe the structure of a red blood cell. What advantage does this unique shape give the red blood cell that helps it perform its function? Both aplastic anemia and pernicious anemia are characterized by low red blood cell count. Explain the difference in their causes. Slide 22 What is the buffy coat? Explain the function of neutrophils and monocytes. Explain the function of lymphocytes. Explain the function of eosinophils and basophils. Distinguish between leukopenia and leukocytosis. Slide 23 How is hemophilia transmitted? What blood clotting factors can be affected? Explain the process of blood clot formation Explain how heparin inhibits blood clot formation Differentiate between the process of blood clot formation and the process of blood agglutination. Slide 24 Differentiate between a thrombus and an embolus. Explain how type A blood differs from type B blood and type O blood. Explain the cause of erythroblastosis fetalis. Why is the first Rh positive baby born to an Rh negative mother usually unaffected? Slide 25 Thanks for attending! See you in discussion!